Encorafenib in combination with binimetinib for unresectable or metastatic melanoma with BRAF mutations

Title
Encorafenib in combination with binimetinib for unresectable or metastatic melanoma with BRAF mutations
Authors
Keywords
-
Journal
Expert Review of Clinical Pharmacology
Volume -, Issue -, Pages -
Publisher
Informa UK Limited
Online
2019-01-17
DOI
10.1080/17512433.2019.1570847

Ask authors/readers for more resources

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started